CTMX
Price
$1.04
Change
-$0.09 (-7.96%)
Updated
Dec 18, 04:10 PM (EDT)
70 days until earnings call
NRSN
Price
$1.15
Change
+$0.05 (+4.59%)
Updated
Dec 18, 04:25 PM (EDT)
91 days until earnings call
Ad is loading...

CTMX vs NRSN

Header iconCTMX vs NRSN Comparison
Open Charts CTMX vs NRSNBanner chart's image
CytomX Therapeutics
Price$1.04
Change-$0.09 (-7.96%)
Volume$100
CapitalizationN/A
NeuroSense Therapeutics
Price$1.15
Change+$0.05 (+4.59%)
Volume$300
CapitalizationN/A
CTMX vs NRSN Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. NRSN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and NRSN is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CTMX: $1.13 vs. NRSN: $1.09)
Brand notoriety: CTMX and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 64% vs. NRSN: 299%
Market capitalization -- CTMX: $90M vs. NRSN: $25.21M
CTMX [@Biotechnology] is valued at $90M. NRSN’s [@Biotechnology] market capitalization is $25.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTMX and NRSN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 5 TA indicator(s) are bullish while NRSN’s TA Score has 5 bullish TA indicator(s).

  • CTMX’s TA Score: 5 bullish, 5 bearish.
  • NRSN’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than NRSN.

Price Growth

CTMX (@Biotechnology) experienced а -10.32% price change this week, while NRSN (@Biotechnology) price change was +6.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

CTMX is expected to report earnings on Feb 26, 2025.

NRSN is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($90M) has a higher market cap than NRSN($25.2M). NRSN YTD gains are higher at: 38.853 vs. CTMX (-27.097).
CTMXNRSNCTMX / NRSN
Capitalization90M25.2M357%
EBITDA8.55MN/A-
Gain YTD-27.09738.853-70%
P/E Ratio7.19N/A-
Revenue127MN/A-
Total Cash118MN/A-
Total Debt10.6MN/A-
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXNRSN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWIN2.000.02
+1.01%
Solowin Holdings Ordinary Share
ADDDF256.00-0.21
-0.08%
adidas AG
FOR26.99-0.33
-1.21%
Forestar Group
AKZOY19.81-0.44
-2.17%
Akzo Nobel N.V.
ANAB15.99-0.66
-3.96%
AnaptysBio

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-1.74%
MLEC - CTMX
42%
Loosely correlated
-5.74%
BCAB - CTMX
40%
Loosely correlated
-2.96%
TECH - CTMX
39%
Loosely correlated
-1.17%
PYXS - CTMX
39%
Loosely correlated
-2.98%
CRBU - CTMX
37%
Loosely correlated
+1.57%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+23.35%
SLRX - NRSN
32%
Poorly correlated
-4.06%
CTMX - NRSN
31%
Poorly correlated
-1.74%
DNLI - NRSN
29%
Poorly correlated
-0.30%
TARS - NRSN
27%
Poorly correlated
+2.96%
VKTX - NRSN
27%
Poorly correlated
-1.12%
More